FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Resmed Class 1 Recall of Astral Ventilators

Resmed recalls its Astral 100/150 ventilator system due to the potential for a supercapacitor electrolyte leakage on the printed circuit board assembl...

latest-news-card-1
FDA General

Dr. Oz Emerges as Potential Successor to RFK Jr. at HHS, Report Says

Bloomberg reports that Centers for Medicare & Medicaid Services head Mehmet Oz is increasingly viewed inside the Trump administration as the leading c...

latest-news-card-1
Human Drugs

Dr. Reddys Gets FDA-483 After Pre-Approval Inspection

FDA issues Dr. Reddys a three-observation Form FDA-483 following a pre-approval inspection and Good Manufacturing Practices inspection at the companys...

latest-news-card-1
Medical Devices

FDA De Novo OK for CaRi-Heart Coronary Inflammation Technology

FDA grants de novo authorization for Caristo Diagnostics CaRi-Heart coronary inflammation technology.

latest-news-card-1
Biologics

FDA Panel Votes Down Capricor's Duchenne Cell Therapy

An FDA advisory committee votes against recommending approval for Capricor Therapeutics' investigational cell therapy deramiocel, for treating cardiom...

latest-news-card-1
Human Drugs

FDA Accepts for Review Saol Therapeutics SL1009 NDA Resubmission

FDA accepts for review a Saol Therapeutics NDA resubmission for SL1009 (sodium dichloroacetate, or DCA), an investigational treatment for pyruvate deh...

latest-news-card-1
Human Drugs

5 Observations in 17-Page Strides Pharma FDA-483

FDA releases the 17-page form FDA-483 following a May inspection at Indias Strides Pharma Science drug manufacturing facility in Bangalore.

latest-news-card-1
Human Drugs

FDA Sends Congress FY 2024 Pediatric Device Approval Report

In its report on FY 2024 approvals of medical devices for pediatric uses, FDA says that 19 of the 56 device approvals that year were indicated for use...

Human Drugs

Novel Laboratories FDA-483 Out

FDA releases the form FDA-483 with three observations from an inspection at the Novel Laboratories (Lupin) drug manufacturing facility in Somerset, NJ...

latest-news-card-1
FDA General

FDA Moving to a Shared Services and Inspections Approach

NOTUS reports that FDA will reorganize on 10/1 to a shared services model in which administrative functions are centralized, and inspectors are genera...